Royal Bank of Canada’s Barinthus Biotherapeutics BRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-105
Closed 6636
2025
Q1
$0 Buy
+105
New ﹤0.01% 6418
2024
Q3
Sell
-4,065
Closed -$6K 6401
2024
Q2
$6K Buy
+4,065
New +$6K ﹤0.01% 6083
2023
Q4
Sell
-1,000
Closed -$3K 6581
2023
Q3
$3K Buy
+1,000
New +$3K ﹤0.01% 6207